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Figure 1. (A), Axial T1-weighted image shows diffuse cerebral white-matter abnormalities with frontoparietal subcortical cysts
(arrows). (B), Axial FLAIR image exhibits subcortical cysts (arrows) in the anterior temporal lobe intermingled with diffuse white-
matter hyperintensity. (C) and (D), Axial T2-weighted images with diffuse white-matter abnormalities, the external and extreme
capsules are involved and the posterior limb of the internal capsule shows a double-line of abnormal intensity (arrows in D). (E),
Coronal T2-weighted image highlights a diffuse brain swelling with white-matter hyperintensity and persistence of the cavum
septum pellucidum (arrow). (F), Sagittal T1-weighted image with fat suppression and after endovenous gadolinium contrast, note
the cranio-facial disproportion without abnormal enhancement. The corpus callosum is relatively spared.
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A ten-year-old boy with macrocephaly. His head circumfer-
ence soon after birth started growing above normal.
Developmental milestones were normal and neurological exam-
ination showed mild hypotonia in the first years of life. The only
complain is frequent falls, without cerebellar or motor abnor-
malities on neurological examination. MLC diagnosis was based
on MRI findings (Figures 1 and 2). The absence of cerebellar
abnormalities in this case is useful to rule out congenital mus-
cular dystrophy in patient with macrocephaly1.
MLC is associated with MCL1 gene mutation in 70% of
the cases2, leading to disbalanced intracelullar ion concen-
tration and astrogliosis3,4.
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Figure 2. Short TE (31ms) proton-spectroscopy in a control (A) and in the patient with MLC (B) demonstrates mild increased
concentration of choline (Cho, in 3.24 ppm) and myoinositol (mI in 3.56 ppm), there is also mild decreased NAA (this pattern is
compatible with mild disease, indicating gliosis and rarefaction of the white-matter). In patients with another spectrum of this
disease (severe neurological deterioration), the white-matter is totally cystic and proton-spectroscopy shows peaks of lactate (in
1.33 ppm) and glucose (in 3.4 and 3.8 ppm).
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